Skip To Main Content
Myriem Boufraqech on Muck Rack

Myriem Boufraqech

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Myriem

Contact Myriem, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Anaplastic thyroid cancer: genomic landscape, molecular drivers and novel therapeutics

|
By Electron Kebebew, Shawn Noronha, Myriem Boufraqech
| Nature Verified
Abstract Anaplastic thyroid cancer (ATC) is one of the most aggressive human malignancies, defined by rapid progression, early metastasis and resistance to nearly all standard therapies. Although it accounts for less than 2% of thyroid cancers, ATC causes a disproportionate number of thyroid cancer-related deaths, with median overall survival rarely exceeding 10 months. Most patients present with unresectable or metastatic disease, leaving few curative options.
Open in Who Shared Issue with article?
See all 1 articles